Researchers have created a $65 test designed to show which prostate cancer patients will respond to Pfizer’s Xtandi and Johnson & Johnson’s Zytiga.
HTG Molecular Diagnostics is teaming up with Spain’s Instituto Valenciano de Oncología to develop a score to predict breast cancer recurrence.
How PAREXEL's New Ecosystem of Technology, Processes and Expertise is Transforming Drug Development
IBM developed a method combining deep learning and visual analytics to detect and gauge the severity of diabetic retinopathy from an eye image.
Verily launched Project Baseline, which aims to better understand what it means to be healthy and how health transitions to disease.
With pressures to fast-track clinical development, the pharmaceutical industry recognizes the value of improving internal clinical data management processes.…
Bristol-Myers Squibb and Denmark’s Nordic Bioscience inked a deal to develop biomarker technology to diagnose and monitor nonalcoholic steatohepatitis.
Verily has unveiled its long-discussed wearable health tracker, Study Watch.
Massachusetts biotech Sentien has filed for approval to start clinical trials of a blood filtering device packed with bone marrow cells for severe cases of…
Apple has tasked a team of 30 engineers with developing a continuous noninvasive blood sugar monitoring technology, according to CNBC.
University of Utah researchers have developed “smart glasses” that mimic the function of the eye’s lens and automatically focus.
The United Kingdom is making mechanical thrombectomy more widely available for patients who have suffered strokes.